Researchers at Nova Southeastern University were investigators in a major multi-center randomized clinical trial that will be published shortly in the American Journal of Preventive Medicine. The work, supported by grants from the Centers for Disease Control and Prevention, involved developing and testing an innovative intervention intended to prevent alcohol-exposed pregnancies (AEPs). While Fetal Alcohol Syndrome (FAS) is the best known and most severe effects of prenatal alcohol consumption (occurring most often in children born to women who drink heavily throughout their pregnancy), mothers who consume smaller amounts of alcohol during their pregnancy can also give birth to children who manifest fewer and more subtle abnormalities, such as attention and memory problems, impulsivity, aggression or social problemstypically referred to as fetal alcohol effects. Such problems with AEPs are estimated to be three to four times more prevalent than FAS. Yet, the problem of preventing alcohol-exposed pregnancies is formidable. For example, half of women who become pregnant say they did not plan to become pregnant, and it takes relatively little alcohol use especially during the first trimester of a womens pregnancy to impact the fetus. Thus, women at risk of an AEP will need to be persuaded that (1) they are at risk of becoming pregnant, (2) they are at risk of an alcohol-exposed pregnancy, and (3) to avoid an alcohol-exposed pregnancy they must stop or curtail their drinking before they become pregnant or avoid becoming pregnant.
(l-r) Dr. Mark Sobell; Grant Coordinator Burt Bolton; Dr. Linda Sobell; and Dr. Ken Johnson















